Gyon Technologies Capital Management, LP Biocryst Pharmaceuticals Inc Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $581,363 - $993,750	-50,291 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $562,253 - $777,498	50,291 New	50,291 $697,000
Q3 2020 Nov 16, 2020	SELL	$3.43 - $5.53 $302,676 - $487,989	-88,244 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $167,663 - $495,048	88,244 New	88,244 $420,000
Q1 2020 May 15, 2020	SELL	$1.6 - $4.11 $18,961 - $48,707	-11,851 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $18,843 - $40,885	11,851 New	11,851 $41,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.45B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.